Skip to main content

Table 2 Distribution of HCV genotypes in patients subjected to different types of treatments (N = 136)

From: Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients

HCV Genotypes

Treatment type

 

IFNα & RBV

(%)

PegIFN & RBV

(%)

3a

78(90.6)

33 (66)

3b

None

1 (2)

1a

1 (1.2)

5 (10)

3a/1a

None

4 (8)

3a/1b

None

2 (4)

2b

1 (.7)

none

Untypable

6 (6.9)

5 (10)

Total

86

50

  1. HCV: hepatitis C virus; INF: interferon; Peg: pegylated; RBV: ribavirin